Exemestane Tablet
Product Images NDC 0832-0595

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 0832-0595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Exemestane 01)

Chemical structure of exemestane showing the steroidal backbone with ketone and methyl groups, consistent with the active ingredient exemestane.*

FDA Label Image

Figure 1 (Exemestane 02)

A Kaplan-Meier survival curve comparing disease-free survival duration in months between patients treated with Exemestane and Tamoxifen. The graph shows the proportion surviving over time, with data on hazard ratio, confidence interval, p-value, and number of patients and events for each treatment group.*

FDA Label Image

Figure 2 (Exemestane 03)

A Kaplan-Meier survival curve graph comparing the probability over time in weeks of two treatments: Exemestane and Megestrol Acetate. The solid line represents Exemestane with 270 events out of 366 patients, and the dashed line represents Megestrol Acetate with 305 events out of 408 patients. The vertical axis shows probability ranging from 0.0 to 1.0, and the horizontal axis shows time in weeks from 0 to 150.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Label for Exemestane Tablets, USP 25 mg, a prescription oral tablet. The package contains 30 tablets and is manufactured for Upsher-Smith Laboratories, LLC. The label includes dosage and storage information and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.